Literature DB >> 31828831

Goodbye to all that.

Adam Cohen.   

Abstract

Year:  2019        PMID: 31828831      PMCID: PMC6955395          DOI: 10.1111/bcp.14124

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Should we tolerate tolerability as an objective in early drug development?

Authors:  A Cohen
Journal:  Br J Clin Pharmacol       Date:  2007-09       Impact factor: 4.335

2.  Publishing: The peer-review scam.

Authors:  Cat Ferguson; Adam Marcus; Ivan Oransky
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

3.  Industrialized research in the BJCP: a neo-Luddite view.

Authors:  Adam F Cohen; James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

4.  Organised crime against the academic peer review system.

Authors:  Adam Cohen; Smita Pattanaik; Praveen Kumar; Robert R Bies; Anthonius de Boer; Albert Ferro; Annette Gilchrist; Geoffrey K Isbister; Sarah Ross; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2016-06       Impact factor: 4.335

5.  On authorship in the BJCP.

Authors:  Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2017-10       Impact factor: 4.335

Review 6.  Integrating data from the Investigational Medicinal Product Dossier/investigator's brochure. A new tool for translational integration of preclinical effects.

Authors:  Joop van Gerven; Adam Cohen
Journal:  Br J Clin Pharmacol       Date:  2018-05-15       Impact factor: 4.335

7.  Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.

Authors:  A F Cohen; L Ashby; D Crowley; G Land; A W Peck; A A Miller
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

  7 in total
  1 in total

1.  Nulelìntàm èli Paèkw.

Authors:  Serge Cremers
Journal:  Br J Clin Pharmacol       Date:  2020-01-07       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.